ϵͳÐÔºì°ßÀÇ´¯(systemic lupus erythematosus,SLE)ÊÇÒ»ÖÖ×ÔÉíÃâÒ߽鵼µÄÂýÐÔÑ×Ö¢ÐÔ¼²²¡£¡£¡£¡£ ¡£¬ £¬£¬£¬£¬Æä·¢²¡»úÖƲ»Ã÷£¬ £¬£¬£¬£¬ÒÔ¶àϵͳÆ÷¹ÙË𺦼°¶àÖÖ×ÔÉí¿¹ÌåµÄ±¬·¢ÎªÖ÷ÒªÌص㡣¡£¡£¡£ ¡£
SLEËðÉËƵÂÊ×î¸ßµÄÆ÷¹ÙϵͳÊǼ¡Èâ¹Ç÷À¡¢ÉöÔà¡¢ÐÄѪ¹ÜºÍÉñ¾¾«Éñϵͳ£¬ £¬£¬£¬£¬×î¸ßµÄËðÉËÀÛ»ý±¬·¢ÔÚ¼²²¡µÄÇ°2Äê¡£¡£¡£¡£ ¡£
50~70%µÄSLE»¼ÕßÓе䷶µÄÉöÀÛ¼°ÁÙ´²ÌåÏÖ£¬ £¬£¬£¬£¬ÀÇ´¯ÉöÑ×(LN)ÊÇSLE·¢²¡ºÍסԺµÄÖ÷ÒªÔµ¹ÊÔÓÉ£¬ £¬£¬£¬£¬LNÏà¹ØµÄÉöË¥½ßÊÇSLEµÄÖ÷ÒªéæÃüÔµ¹ÊÔÓÉÖ®Ò»¡£¡£¡£¡£ ¡£
Îü¸½ÔÀí
DNAÃâÒßÎü¸½ÖùÊÇÔÚÌ¿»¯Ê÷Ö¬ÉÏÀο¿Ð¡Å£ÐØÏÙDNAÖƳÉDNAÃâÒßÎü¸½¼Á£¬ £¬£¬£¬£¬ÓëÖùÌåµÈ×é×°³ÉÃâÒßÎü¸½Öù£¬ £¬£¬£¬£¬¾ßÓжԿ¹DNA¿¹ÌåºË¿¹ÌåµÄÌØÒìÐÔʶ±ðºÍÎü¸½ÄÜÁ¦¡£¡£¡£¡£ ¡£
³£¼ûÎü¸½¼Æ»®[3-5]
²Î¿¼ÎÄÏ×£º
[1]ÀõÕ¼¹ú£¬ £¬£¬£¬£¬ÕÅ·î´º£¬ £¬£¬£¬£¬ÔøС·å.·çʪÃâÒßѧ[M].ÈËÃñ¾üÒ½³öÊéÉ磬 £¬£¬£¬£¬2014,91-93.
[2]Nossent J,Kiss E,Rozman B,et al.Disease activity and damage accrual during the early disease course in a multinationalinception cohort of patients with systemic lupus erythematosus[J].Lup,2010,19(8):949 -956.
[3]Áõ·²£¬ £¬£¬£¬£¬ÒüÞ±.DNAÃâÒßÎü¸½ÖÎÁÆС¶ùϵͳÐÔºì°ßÀÇ´¯¶ÔѪÇåD-¶þ¾ÛÌ壬 £¬£¬£¬£¬¶ù-23ˮƽµÄÓ°Ïì[J].Äϲý´óѧѧ±¨£ºÒ½Ñ§°æ£¬ £¬£¬£¬£¬2020,60(1):4.
[4]¼ÖÓ¨£¬ £¬£¬£¬£¬DNAÃâÒßÎü¸½ÑªÒº¹àÁ÷Æ÷ÖÎÁÆÀÇ´¯ÐÔÉöÑ×µÄЧ¹ûÊÓ²ì[J].ÖйúÏÖ´úÒ©ÎïÓ¦Ó㬠£¬£¬£¬£¬2018,12(17);3.
[5]×ó·¼·¼£¬ £¬£¬£¬£¬ÐíÇÙЦ£¬ £¬£¬£¬£¬Ô¬Ò㣬 £¬£¬£¬£¬µÈ£¬ £¬£¬£¬£¬ÃâÒßÎü¸½ÖÎÁÆϵͳÐÔºì°ßÀÇ´¯31ÀýÁÙ´²ÁÆЧÊÓ²ì[C]//ÌìÏ·çʪ²¡Ñ§Êõ¾Û»á.ÖйúÖÐÎ÷ҽ͎áѧ»á£¬ £¬£¬£¬£¬2015.
DNA230+HA280Ë«ÖØÎü¸½£¬ £¬£¬£¬£¬¿ìËÙɨ³ý
²Î¿¼ÎÄÏ×£º
[1]µØ½²¨£¬ £¬£¬£¬£¬¶ÅÅô£¬ £¬£¬£¬£¬ÃâÒßÎü¸½ÖÎÁƼ±ÐÔ¸ñÁÖ°ÍÀû×ÛºÏÕ÷×ÔÀý[1].ÌìÏÂ×îÐÂҽѧÐÅÏ¢ÎÄÕª£¬ £¬£¬£¬£¬2016,16(46):177-179.
[2]¶Ï볡£¡£¡£¡£ ¡£¬ £¬£¬£¬£¬ÕÔÁú±ó£¬ £¬£¬£¬£¬ÖìÉÜÄ꣬ £¬£¬£¬£¬µÈ.DNAÃâÒßÎü¸½ÖÎÁÆ×ÔÉíÃâÒßÐԸβ¡µÄÁÙ´²ÁÆЧ[J].Öаë¸Î´¥²¡ÔÓÖ¾£¬ £¬£¬£¬£¬2013,21(4):315-317.
[3]ÍõÉÕ¾ü£¬ £¬£¬£¬£¬º«¾Û·½£¬ £¬£¬£¬£¬¸êº£Ç࣬ £¬£¬£¬£¬µÈ.DNAÃâÒßÎü¸½ÖÎÁÆ×ÔÉíÃâÒßÐÔÑ×ÐÔ¼¡²¡µÄÁÙÄ©ÁÆЧ[J].ÊÊÓÃҽѧÔÓÖ¾£¬ £¬£¬£¬£¬2015,31(4):678-679.
[4]ÕÔÁúÃ㬠£¬£¬£¬£¬ÐÁÐ۲ȣ¬ £¬£¬£¬£¬ËïÓ껪£¬ £¬£¬£¬£¬µÈ.ÃâÒßÎüÉäÖÎÁÆÄÑÖÎÐÔÀà·çʪÊàŦÑ×µÄÁÙ´²Ó¦ÓÃ[J].ÖйúѪҺ¾»»¯£¬ £¬£¬£¬£¬2017,16(10):681-685.
[5]Õ;¯Õ £¬£¬£¬£¬×¯Ó £¬£¬£¬£¬ÁõÁ¿.DNAÃâÒßÎü¸½ÁÆ·¨ÖÎÁÆ»ý´¯¼äÖÊÐÔ·ÎÑ׵ĽüÆÚÁÆЧ¼°Çå¾²ÐÔÆÊÎöС¹ãÎ÷Ò½¿Æ´óѧѧ±¨£¬ £¬£¬£¬£¬2018,35(1):61-64.
[6]ÐÁæ㬠£¬£¬£¬£¬ÑªÒº¾»»¯ÍŽáDNAÃâÒ¹Îü¸½ÖιãÖØ֢ϵͳÐÔºì°à¶À¸ÐµÄЧ¹û[J].ÊÊÓÃÁÙ´²Õչ˻¤Ê¿Ñ§ÔÓÖ¾£¬ £¬£¬£¬£¬2019¡£¡£¡£¡£ ¡£(14):62-63.
[7]°¢Èð¾ê£¬ £¬£¬£¬£¬¶Ñ £¬£¬£¬£¬Ðì´ïÁ¼£¬ £¬£¬£¬£¬µÈ.ѪҺ¹àÁ÷ÖÎÁƶùͯÖØÖ¢¹ýÃôÐÔº®°¸µÄÁÆЧÊÓ²ì[J].°²»Õҽѧ£¬ £¬£¬£¬£¬2014(6):721-723.
[8]±«Ïþ»Ô ·³¤ Îâ־ƽ ³ÌÏþÃà Óá»ÛÇÙ ê» ÎÄ.ѪҺ¹àÁ÷ÖÎÁÆÖØÖ¢Ò©ÕîÁÙ´²ÁÆЧÊÓ²ì[J],Öлª¼±ÕïҽѧÔÓÖ¾£¬ £¬£¬£¬£¬2016(25):97.
[9]ÁõÓñ·ç.ѪҺ¹àÁ÷ÔÚÌìðå´¯ÖÎÁÆÖеÄÓ¦ÓÃÓëÕչ˻¤Ê¿].½ñÊÀ»¤Ê¿(ÖÐ×Ô¿¯),2018,01(V.25):49-50.
[10]ÎâÈð¶÷£¬ £¬£¬£¬£¬»ÆÔÊ£¬ £¬£¬£¬£¬¼¯¹ð±æ.ѪҺ¹àÁ÷ÖÎÁÆÒøм²¡11ÀýµÄÁÆЧÊÓ²ì].¹ãÎ÷ҽѧ£¬ £¬£¬£¬£¬2009,31(010):1565-1566
